Despite the Hoopla, Vaccines Should Be in Reach This Cough-and-Cold Season
Recommendations surrounding covid vaccinations and other such shots have been confusing. Ultimately, though, little has changed. Here鈥檚 what you need to know.
FDA
41 - 60 of 476 Results
-
Starting To Feel the Shutdown鈥檚 Bite
Episode 417The government shutdown continues with no end in sight, and while it theoretically should not affect entitlement programs, the lapse of some related authorizations 鈥 like for Medicare telehealth programs 鈥 is leaving some doctors and patients high and dry. Meanwhile, the FDA quietly approved a new generic abortion pill. Sarah Karlin-Smith of Pink Sheet, Tami Luhby of CNN, and Alice Miranda Ollstein of Politico join 吃瓜不打烊鈥 Julie Rovner to discuss those stories and more. Also, Rovner interviews Sarah Grusin of the National Health Law Program.
-
鈥楬istoric鈥 White House Announcement on Autism and Tylenol Causes Confusion
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
By Amy Maxmen -
Off-Label Drug Helps One Boy With Autism Speak, Parents Say. But Experts Want More Data.
This week, the FDA began the process of approving leucovorin, an inexpensive, generic drug derived from folic acid, to help children diagnosed with autism.
-
Trump Claims ‘No Downside’ to Avoiding Tylenol During Pregnancy. He’s Wrong.
Doctors say acetaminophen, the main ingredient in Tylenol, is safe to take during pregnancy. Other over-the-counter pain relievers such as aspirin and ibuprofen aren鈥檛 recommended because they can harm fetal development. Untreated fever in pregnancy can pose maternal and fetal health risks.
-
Journalists Follow the Fallout of CDC Director’s Firing and Trump’s Health Policies
吃瓜不打烊 journalists made the rounds on national and local media recently to discuss topical stories. Here鈥檚 a collection of their appearances.
-
Under Trump, FDA Seeks To Abandon Expert Reviews of New Drugs
Advisory committee meetings help FDA scientists make decisions and increase public understanding of drug regulation, and abandoning them doesn鈥檛 make sense, former officials said.
By Arthur Allen -
RFK Jr. Said 鈥楨verybody Can Get鈥 a Covid Vaccine. Is That True?
Although the FDA has approved the vaccines for anyone 65 or older and anyone at least 6 months old who is at risk of a severe covid infection, barriers to coverage and access persist.
On Capitol Hill, RFK Defends Firings at CDC
Episode 412A combative Robert F. Kennedy Jr, the U.S. secretary of health and human services, appeared before a Senate committee Thursday, defending his firing of the newly confirmed director of the Centers for Disease Control and Prevention as well as other changes that could limit the availability of vaccines. Meanwhile, Congress has only a few weeks to complete work on annual spending bills to avoid a possible government shutdown and to ward off potentially large increases in premiums for Affordable Care Act health plans. Jessie Hellmann of CQ Roll Call, Sarah Karlin-Smith of Pink Sheet, and Alice Miranda Ollstein of Politico join 吃瓜不打烊鈥 Julie Rovner to discuss these stories and more. Also this week, Rovner interviews 吃瓜不打烊鈥 Tony Leys, who discusses his 鈥淏ill of the Month鈥 report about a woman鈥檚 unfortunate interaction with a bat 鈥 and her even more unfortunate interaction with the bill for her rabies prevention treatment.
-
FTC Has Long Said Products Must Back Up Health Claims. A MAHA Lawsuit Would Upend That.
Xlear, a maker of xylitol gum, has sued the Federal Trade Commission, saying the onus should be on government to prove that ingredients don鈥檛 live up to advertised claims. RFK Jr.鈥檚 鈥渕edical freedom鈥 allies have rallied to the cause.
By Arthur Allen Trump Further Politicizes Science
Episode 410President Donald Trump鈥檚 latest executive order about science and medicine seeks to take funding decisions out of the hands of career scientists and give them to political appointees instead. And a gunman, reportedly disgruntled over covid vaccines, shoots at the headquarters of the Centers for Disease Control and Prevention, killing a law enforcement officer. Alice Miranda Ollstein of Politico, Shefali Luthra of The 19th, and Sarah Karlin-Smith of the Pink Sheet join 吃瓜不打烊鈥 Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Aaron Carroll, president and CEO of the health services research group AcademyHealth, about how to restore the public鈥檚 trust in public health.
-
Listen: Regulatory Rollbacks and Federal Layoffs Threaten America鈥檚 Food Supply
The Trump administration鈥檚 anti-regulatory approach and cost-cutting moves risk unraveling the system of checks and balances that helps ensure the safety of the U.S. food supply, say consumer advocates and former employees of the FDA and Department of Agriculture.
Kennedy Cancels Vaccine Funding
Episode 409The Health and Human Services secretary is winding down nearly $500 million in mRNA research funding, citing false claims that the technology is ineffective against respiratory illnesses 鈥 and notching a victory for critics of the covid vaccines. And President Donald Trump is demanding drugmakers drop their prices, quickly, but it鈥檚 unclear how he could make them comply. Lauren Weber of The Washington Post, Sandhya Raman of CQ Roll Call, and Sarah Karlin-Smith of the Pink Sheet join 吃瓜不打烊鈥 Emmarie Huetteman to discuss these stories and more.
-
Sorting Out Covid Vaccine Confusion: New and Conflicting Federal Policies Raise Questions
Should you get vaccinated? Will your insurer pay for it? And will you still be able to find a vaccine? 吃瓜不打烊 tries to sort out where things stand.
Next on Kennedy鈥檚 List? Preventive Care and Vaccine Harm
Episode 408Robert F. Kennedy Jr., the secretary of Health and Human Services, is eyeing an overhaul of two more key entities as part of his ongoing effort to reshape health policy. And President Donald Trump signed an executive order last week that would enable localities to force some homeless people into residential treatment. Anna Edney of Bloomberg News, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine, and Shefali Luthra of The 19th join 吃瓜不打烊鈥 Julie Rovner to discuss these stories and more. Also, Rovner interviews Sara Rosenbaum, one of the nation鈥檚 leading experts on Medicaid, to mark Medicaid鈥檚 60th anniversary this week.
Here Come the ACA Premium Hikes
Episode 407Medicaid may have monopolized Washington鈥檚 attention lately, but big changes are coming to the Affordable Care Act as well. Meanwhile, Americans are learning more about what鈥檚 in Trump鈥檚 big budget law, and polls suggest many don鈥檛 like what they see. Julie Appleby of 吃瓜不打烊, Jessie Hellmann of CQ Roll Call, and Alice Miranda Ollstein of Politico join 吃瓜不打烊鈥 Julie Rovner to discuss these stories and more. Also this week, Rovner interviews historian Jonathan Oberlander to mark Medicare鈥檚 60th anniversary.
The Senate Saves PEPFAR Funding 鈥 For Now
Episode 406The Senate narrowly approved the Trump administration鈥檚 request to claw back about $9 billion for foreign aid and public broadcasting but refused to cut funding for the international AIDS/HIV program PEPFAR. Meanwhile, a federal appeals court ruled that West Virginia can ban the abortion pill mifepristone, which could allow states to block other FDA-approved drugs. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine, Shefali Luthra of The 19th, and Sandhya Raman of CQ Roll Call join 吃瓜不打烊鈥 Julie Rovner to discuss these stories and more.
-
What RFK Jr. Isn鈥檛 Talking About: How To Make Vaccines Safer
Vaccines are under fire from the top of the Trump administration. Federal programs to monitor them and make them safer have always been underfunded.
By Arthur Allen -
A Revolutionary Drug for Extreme Hunger Offers Clues to Obesity鈥檚 Complexity
A new drug is helping families who鈥檝e spent years padlocking fridges, chaining garbage cans, and hiding food as their children with Prader-Willi syndrome deal with unrelenting hunger. But additional progress 鈥 and a broader understanding of obesity 鈥 is now under threat as the government dismantles the pipeline for promising new research.
-
Two Patients Faced Chemo. The One Who Survived Demanded a Test To See if It Was Safe.
Worried that President Donald Trump鈥檚 FDA might not act, a panel of cancer experts recommended that doctors consider testing before dosing patients with a commonly used but sometimes deadly cancer drug. It came too late for many patients.
By Arthur Allen